Keyphrases
Chronic Lymphocytic Leukemia
55%
Tumor Antigen
50%
Chronic Lymphocytic Leukemia Cells
50%
Recombinant Expression
50%
T Cell Response
50%
Serologic
50%
Paediatric Acquired Brain Injury
50%
Expression Cloning
50%
Derived Peptide
50%
Human Leukocyte Antigen
50%
Binding Residues
50%
Immunoglobulin
50%
Peptide-modified
50%
Cytotoxic T Cell Response
50%
Caffeine
50%
Neurostimulator
50%
Heteroclitic Peptides
42%
Healthy Donors
25%
Ambulation
25%
T Cells
22%
Immunotherapeutic Strategy
20%
Arousal
18%
Antigen-presenting Cells
17%
Malignant Disease
17%
Tumor
15%
Amino Acid Substitution
14%
MHC Class II
14%
Immune Response
14%
Native Peptides
14%
Tumor Cells
14%
Human Leukocyte antigen-A
14%
Low Immunogenicity
14%
Older African Americans
12%
Wheelchair
12%
Functional Independence
12%
Acquired Brain Injury
12%
Cellular Immune Response
10%
Malignancy
10%
Autoimmune Phenomena
10%
Anti-tumor Response
10%
Antibody Response
10%
Hypogammaglobulinemia
10%
Malignant Tissue
10%
Lymphoma Patients
10%
Aberrant Gene Expression
10%
Transformation Process
10%
Allogeneic
10%
Humoral Immune Response
10%
Expression Pattern
10%
Leukemia-associated Antigen
10%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Leukemia Cell
50%
Tumor Antigen
50%
Acquired Brain Injury
50%
T-Cell Response
50%
Pediatrics
50%
Mobilization
50%
Immunotherapy
50%
K-Complex
37%
T Cell
23%
Diseases
20%
Neoplasm
14%
Pediatrics Patient
12%
Cerebral Hemorrhage
12%
Traumatic Brain Injury
12%
Arteriovenous Malformation
12%
Thumb
12%
Adverse Event
12%
Leukemia Antigen
10%
Hypogammaglobulinemia
10%
Gene Expression
10%
Antibody Response
10%
Cellular Immunity
10%
Cancer
10%
Humoral Immunity
10%
Cytotoxicity
10%
Immune Response
9%
Antigen Presenting Cell
9%
Immunology and Microbiology
T Cell
65%
Immunotherapy
57%
Cytotoxic T Cell
55%
Leukemia Cell
50%
Human Leukocyte Antigen
50%
Intravenous Immunoglobulin
50%
Tumor Antigen
50%
Immunology
50%
Immune Response
24%
Immunogenicity
21%
Major Histocompatibility Complex
21%
Antigen-Presenting Cell
17%
Cytotoxicity
15%
Binding Affinity
14%
Tumor Cell
14%
Adoptive Immunity
8%
Humoral Immunity
8%
Gene Expression
8%
Antibody Response
8%
Leukemia Antigen
8%
Hypogammaglobulinemia
8%
B Cell
7%
Immunoglobulin Gene
7%
Amino Acid Substitution
7%
Dendritic Cell
5%
Cell Line
5%